Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Stimulant medications precipitate Tourette's syndrome.

Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA.

JAMA. 1982 Feb 26;247(8):1168-9.

PMID:
6120250
2.

Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.

Gadow KD, Sverd J.

J Dev Behav Pediatr. 1990 Oct;11(5):269-71; discussion 272. Review. No abstract available.

PMID:
1979565
3.

Tourette's syndrome: are stimulants safe?

Kurlan R.

Curr Neurol Neurosci Rep. 2003 Jul;3(4):285-8. Review.

PMID:
12930697
4.

Pharmacotherapy of Tourette's syndrome and associated disorders.

Cohen DJ, Riddle MA, Leckman JF.

Psychiatr Clin North Am. 1992 Mar;15(1):109-29. Review.

PMID:
1549543
5.
6.

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.

Pringsheim T, Steeves T.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007990. doi: 10.1002/14651858.CD007990.pub2. Review.

PMID:
21491404
7.

Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome.

Robertson MM, Eapen V.

Clin Neuropharmacol. 1992 Oct;15(5):408-25. Review.

PMID:
1358442
8.

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

Stevenson RD, Wolraich ML.

Pediatr Clin North Am. 1989 Oct;36(5):1183-97. Review.

PMID:
2677938
9.

[Chronic tic disorders--chronic mortor or vocal tic disorders and de la Tourette's syndrome].

Kano Y.

Ryoikibetsu Shokogun Shirizu. 2003;(40):65-71. Review. Japanese. No abstract available.

PMID:
14626066
10.

Gilles de la Tourette's syndrome.

Faridi K, Suchowersky O.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S64-71. Review.

PMID:
12691479
11.

The behavioral spectrum of Gilles de la Tourette syndrome.

Cavanna AE, Servo S, Monaco F, Robertson MM.

J Neuropsychiatry Clin Neurosci. 2009 Winter;21(1):13-23. doi: 10.1176/appi.neuropsych.21.1.13. Review.

PMID:
19359447
12.

Tics, Tourette's, and attention deficit hyperactivity disorders: connections and treatment.

Mitchell A, Steffenson N, Hogan H, Gibson FH, Steffenson M.

MCN Am J Matern Child Nurs. 1996 Nov-Dec;21(6):294-300. Review. No abstract available.

PMID:
8952283
13.

[Tics and Gilles de la Tourette syndrome].

Tijero-Merino B, Gómez-Esteban JC, Zarranz JJ.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S17-20. Review. Spanish.

14.

Managing stimulant medication for attention-deficit/hyperactivity disorder.

Wender EH.

Pediatr Rev. 2001 Jun;22(6):183-90. Review. No abstract available. Erratum in: Pediatr Rev 2001 Sep;22(9):292.

PMID:
11389305
15.

Pharmacological options for the treatment of Tourette's disorder.

Jiménez-Jiménez FJ, García-Ruiz PJ.

Drugs. 2001;61(15):2207-20. Review.

PMID:
11772131
16.

Eye signs and tic disorders: Gilles de la Tourette's syndrome.

Goetz CG.

J Am Optom Assoc. 1997 Nov;68(11):688-92. Review.

PMID:
9409103
17.

Clinical management of Tourette's syndrome and associated disorders.

Sandor P.

Can J Psychiatry. 1995 Dec;40(10):577-83. Review.

PMID:
8681254
18.

Recognition and management of Tourette's syndrome and tic disorders.

Bagheri MM, Kerbeshian J, Burd L.

Am Fam Physician. 1999 Apr 15;59(8):2263-72, 2274. Review.

19.

[Searching for Tourette's syndrome gene. Part 1. Heterogeneity of clinical phenotypes].

Kowalska A, Midro AT, Janik P, Gogol A, Służewski W, Rajewski A.

Postepy Hig Med Dosw (Online). 2012 Feb 24;66:85-8. Review. Polish.

20.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Dec;(8):280-90. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):318-27.

PMID:
12603883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk